These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34593269)

  • 1. National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
    Casey RM; Adrien N; Badiane O; Diallo A; Loko Roka J; Brennan T; Doshi R; Garon J; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A10-A16. PubMed ID: 34593269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
    Mphuru A; Li AJ; Kyesi F; Mwengee W; Mazige F; Nshunju R; Shayo B; Giattas MR; Loharikar A; Lyimo D
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A2-A9. PubMed ID: 33962839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal.
    Brennan T; Hidle A; Doshi RH; An Q; Loharikar A; Casey R; Badiane O; Ndiaye A; Diallo A; Loko Roka J; Mejia N; Abimbola T
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A77-A84. PubMed ID: 34955325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
    Egbon M; Ojo T; Aliyu A; Bagudu ZS
    BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.
    Ahmed D; VanderEnde K; Harvey P; Bhatnagar P; Kaur N; Roy S; Singh N; Denzongpa P; Haldar P; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A17-A25. PubMed ID: 34429233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
    Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
    Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
    BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
    Garon JR; Mukavhi A; Rupfutse M; Bright S; Brennan T; Manangazira P; An Q; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A30-A37. PubMed ID: 34144852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
    Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
    S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide introduction of HPV vaccine in Zimbabwe 2018-2019: Experiences with multiple cohort vaccination delivery.
    Carlton JG; Marembo J; Manangazira P; Rupfutse M; Shearley A; Makwabarara E; Hidle A; Loharikar A
    PLOS Glob Public Health; 2022; 2(4):e0000101. PubMed ID: 36962162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of a National HPV vaccination program into Bhutan.
    Dorji T; Tshomo U; Phuntsho S; Tamang TD; Tshokey T; Baussano I; Franceschi S; Clifford G
    Vaccine; 2015 Jul; 33(31):3726-30. PubMed ID: 26057136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign.
    Delany-Moretlwe S; Kelley KF; James S; Scorgie F; Subedar H; Dlamini NR; Pillay Y; Naidoo N; Chikandiwa A; Rees H
    Glob Health Sci Pract; 2018 Oct; 6(3):425-438. PubMed ID: 30143561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020.
    Doshi RH; Casey RM; Adrien N; Ndiaye A; Brennan T; Roka JL; Bathily A; Ndiaye C; Li A; Garon J; Badiane O; Diallo A; Loharikar A
    PLOS Glob Public Health; 2022; 2(4):e0000130. PubMed ID: 36962130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
    Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
    Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.
    Mvundura M; Slavkovsky R; Debellut F; Naddumba T; Bayeh A; Ndiaye C; Anena J; Vodicka E; Diop A; Gamage D; Musanabaganwa C; Tatkan G; Driwale A; Zelalem M; Badiane O; Ginige S; Hamilton E; Sibomana H; Lakew Y; Uwinkindi F; Dhufera A; Ampeire I; Kumar S; Lamontagne DS
    Vaccine; 2023 Nov; 41(49):7435-7443. PubMed ID: 37949752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.
    Tsu VD; LaMontagne DS; Atuhebwe P; Bloem PN; Ndiaye C
    Prev Med; 2021 Mar; 144():106335. PubMed ID: 33678232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
    Simuyemba MC; Chama-Chiliba CM; Chompolola A; Sinyangwe A; Bchir A; Asiimwe G; Chibwesha C; Masiye F
    BMC Infect Dis; 2024 Apr; 24(1):369. PubMed ID: 38565994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.